The units of In vitro CVT,0 and In vivo CVT,0 in Table 3 should both be μmol mL–1. The results, discussions, and conclusions in the original article are not affected by this correction.
. 2024 Mar 5;21(4):2058. doi: 10.1021/acs.molpharmaceut.4c00176
Correction to “Reverse Iontophoresis: Noninvasive Assessment of Topical Drug Bioavailability”
Kieran Moore
, Sébastien Grégoire
, Joan Eilstein
, M Begoña Delgado-Charro
, Richard H Guy
✉
Kieran Moore
Find articles by Kieran Moore
Sébastien Grégoire
Find articles by Sébastien Grégoire
Joan Eilstein
Find articles by Joan Eilstein
M Begoña Delgado-Charro
Find articles by M Begoña Delgado-Charro
Richard H Guy
Find articles by Richard H Guy
✉
Corresponding author.
Received 2024 Feb 17; Collection date 2024 Apr 1.
© 2024 The
Authors. Published by American
Chemical Society
Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
PMCID: PMC10988549 PMID: 38441041
This corrects the article "Reverse
Iontophoresis: Noninvasive Assessment of Topical
Drug Bioavailability" on page 234.
